Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cohen & Steers (CNS) Net Income towards Common Stockholders (2016 - 2026)

Cohen & Steers' Net Income towards Common Stockholders history spans 17 years, with the latest figure at $57.2 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 8.02% to $57.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $166.6 million, a 20.45% increase, with the full-year FY2025 number at $204.6 million, up 25.7% from a year prior.
  • Net Income towards Common Stockholders hit $57.2 million in Q1 2026 for Cohen & Steers, up from $55.6 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for CNS hit a ceiling of $57.2 million in Q1 2026 and a floor of $25.2 million in Q3 2023.
  • Historically, Net Income towards Common Stockholders has averaged $41.6 million across 5 years, with a median of $38.2 million in 2022.
  • The widest YoY moves for Net Income towards Common Stockholders: up 571.47% in 2022, down 47.26% in 2022.
  • Tracing CNS's Net Income towards Common Stockholders over 5 years: stood at $36.9 million in 2022, then tumbled by 31.76% to $25.2 million in 2023, then soared by 119.65% to $55.3 million in 2024, then increased by 0.5% to $55.6 million in 2025, then increased by 2.95% to $57.2 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for CNS at $57.2 million in Q1 2026, $55.6 million in Q3 2025, and $53.8 million in Q2 2025.